ER+ Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference

For Total Health's 2022 Best of Breast Conference, we bring you a case panel discussion focused on ER+ breast cancer.
Our expert panelists include Dr. Reshma Mahtani from Miami Cancer Institute; Dr. Ting Bao from Memorial Sloan Kettering Cancer Center; Dr. Terry Mamounas from Orlando Health Cancer Institute; and Dr. Hatem Soliman from Moffitt Cancer Center.
To obtain credit for this CME activity you must watch the full 2022 Best of Breast Conference Playlist. Information on obtaining CME/CE Credits and MOC points can be found in the playlist description.

[@toma7744]

Recurrence is because they never restore proper ERb1 signaling to counter act ER alpha .... shame what's going on... Hormone imbalances are ignored.

[@gregoryramsey8213]

My gf has stage 2a breast cancer, Er+/HER-2 negative, with three positive lymph nodes with high percentages of estrogen and progesterone. She is 37, has oncotype score of 6, distant reoccurrence score at 11%, with no apparent benefit with chemo. Her ki67 is 7% and her blood work is 19 U/mL. She is planning on doing ovarian suppression. She is grade 2. She had nipple reserving double mastectomy. She’s very healthy. Her mother and grandmother had breast cancer. I know chemo suppresses ovaries (and helps by 5%), but she doesn’t want it. Would adjuvant endocrine therapy be recommended on these results?

[@stellaeze1758]

Thanks you so much Dr Obulor for your ultimate help in curing my cancer permanently, although the word wouldn't believe in herbs. I will because you have shown me the power of these herbs, i sincerely appreciate you Dr 💛